Payload CDMO Solutions

At the forefront of modern therapeutic advancement lies the paradigm of targeted delivery. We recognize the critical role of potent payloads in enabling next-generation biologics, particularly antibody-drug conjugates (ADCs) and other sophisticated targeting modalities. Our specialized payload CDMO solutions are engineered to overcome the unique challenges associated with these highly active molecules, providing seamless integration within our comprehensive Conjugate CDMO Solutions. We empower innovators to harness the full potential of targeted therapies. Explore our broader CDMO Solutions here and delve into conjugate expertise.

Cytotoxic Payload Design and Manufacturing

The cornerstone of many ADCs remains highly potent cytotoxic agents. Our deep expertise spans diverse classes, including auristatins, maytansinoids, camptothecins, and novel tubulin inhibitors or DNA damaging agents. We specialize in:

• Rational Design & SAR Optimization: Leveraging medicinal chemistry insights to tailor payload properties (potency, solubility, stability, metabolic profile) for optimal conjugate performance and therapeutic index. This includes designing novel warheads and modifying existing scaffolds.
• Complex Synthesis & Purification: Developing robust, scalable synthetic routes for intricate molecules, often requiring multi-step organic synthesis under stringent containment (HPAPI handling). Our focus is on achieving exceptional purity through advanced chromatographic techniques (HPLC, SFC).
• Linker-Payload Conjugation-Ready Intermediate Design: Designing and manufacturing payloads pre-functionalized with tailored linkers (cleavable, non-cleavable) or functional groups (e.g., maleimide, DBCO, TCO) for efficient and site-specific conjugation to targeting moieties.
• Stability Profiling & Formulation Support: Conducting rigorous stability studies under various conditions to guide conjugation process development and final drug product formulation.

Oligonucleotide Payload Development and Production

Beyond cytotoxics, oligonucleotides (ASOs, siRNAs) are emerging as powerful payloads for targeted delivery to specific tissues or cells. We provide specialized services for these complex biomolecules:

• Sequence Design & Modification Strategy: Advising on sequence selection, chemical modifications (e.g., phosphorothioate, 2'-O-methyl, 2'-F, GalNAc conjugation for liver targeting), and backbone alterations to enhance stability, efficacy, and reduce off-target effects.
• Solid-Phase Oligonucleotide Synthesis (SPOS): Expertise in large-scale, GMP-grade SPOS using state-of-the-art synthesizers and purification systems (HPLC, PAGE) to produce high-purity oligonucleotides with defined modification patterns.
• Conjugation-Ready Oligonucleotide Engineering: Designing oligonucleotides with terminal functional groups (thiol, amino, azide, alkyne) compatible with bioorthogonal click chemistry or other conjugation methods for precise attachment to antibodies, peptides, or other carriers.
• Analytical Characterization: Comprehensive analytics including MS, HPLC, CE, NMR, endotoxin testing, and potency assays to ensure identity, purity, strength, and quality.

Radionuclide Payload Development and Production

Radionuclides enable both diagnostic imaging and therapeutic applications. Our capabilities support the integration of these sensitive payloads:

• Chelator Design & Conjugation: Expertise in selecting and synthesizing appropriate bifunctional chelators with high affinity and selectivity for specific radionuclides. We conjugate chelators to targeting vectors.
• Radiolabeling Process Development: Developing robust, efficient radiolabeling protocols under controlled environments, optimizing parameters for high specific activity, radiochemical purity, and stability.
• Analytical Methods for Radiopharmaceuticals: Implementing specialized QC methods, including radio-HPLC, radio-TLC, and gamma counting, to assess radiochemical purity, identity, and specific activity.

Fluorescent Payloads for Diagnostic & Research

While not always therapeutic, fluorophores are crucial payloads for diagnostic imaging, biodistribution studies, and cellular tracking. Our services include:

• Fluorophore Selection & Engineering: Advising on optimal fluorophores (e.g., Cy dyes, Alexa Fluors, near-infrared dyes) based on excitation/emission profiles, brightness, photostability, and biocompatibility.
• Site-Specific Conjugation: Developing methods to conjugate fluorophores site-specifically to targeting molecules without compromising target binding or fluorophore performance.
• Conjugate Characterization: Validating conjugate integrity, fluorescence properties, labeling efficiency, and target binding post-labeling.